Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook
...rther study cethromycin as a potential broad-spectrum medical countermeasure; Presented a poster titled, "Pro-apoptotic Screening of Novel Aza triterpenoids through Structure-Activity Relationship Investigation," at the 237th American Chemical Society meeting in Salt Lake City, UT; and Provided a c...Maslinic acid provides a natural defense against colon cancer
...cancer of the colon. A wide range of studies in recent years has shown that triterpenoids hinder carcinogenesis by intervening in pathways such as carcinogen activat...t, cell differentiation and the induction of apoptosis in cancer cells. triterpenoids are compounds present in a wide range of plants used in traditional medicin...Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer
IRVING, Texas--(BUSINESS WIRE)--Apr 25, 2007 - Reata Pharmaceuticals, Inc. today announced the publication of a review article covering the company's Synthetic Triterpenoid programs in the May 2007 issue of the prestigious journal "Nature Reviews Cancer." The article, "Triterpenoids and rexinoids ...Plant-derived molecules, genetic manipulation point to future chemoprevention methods
...in strain A/J mice New synthetic drugs called triterpenoids which owe their origins to plant molecules have de...er. We think this study shows a promising role for triterpenoids and the drug LG100268 in stopping lung tumor growt...l of estrogen receptor-negative breast cancer triterpenoids and the rexinoid experimental drug LG100268 were a...New compound protects against liver cancer
...February 15, 2006, issue of the journal Cancer Research. CDDO-Im is a synthetic compound that belongs to a class of cancer-fighting compounds called triterpenoids under development by Dr. Michael Sporn and other study co-authors at Dartmouth Medical School. It is derived from oleanolic acid, a naturally occurrin...